Atharva Biosciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.15 M
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
- Revenue Growth -98.89%
- Profit Growth -555.68%
- Ebitda -625.85%
- Net Worth -80.38%
- Total Assets -19.38%
About Atharva Biosciences
Atharva Biosciences Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 December 2004 and has a history of 20 years and one month. Its registered office is in New Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Mamta Agnihotri, Manisha Agnihotri, Ashutosh Vats, and One other member serve as directors at the Company.
Company Details
- Location
New Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33111DL2004PTC131737
- Company No.
131737
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 2004
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Healthcare
Who are the key members and board of directors at Atharva Biosciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mamta Agnihotri  | Director | 01-Aug-2005 | Current |
| Manisha Agnihotri | Director | 01-Nov-2018 | Current |
| Ashutosh Vats | Director | 31-Dec-2004 | Current |
| Abhay Vats | Director | 31-Dec-2004 | Current |
Financial Performance of Atharva Biosciences.
Atharva Biosciences Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 98.89% decrease. The company also saw a substantial fall in profitability, with a 555.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 80.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atharva Biosciences?
In 2019, Atharva Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Atharva Biosciences?
Unlock and access historical data on people associated with Atharva Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atharva Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atharva Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
